NCT06276933 A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Status NOT_YET_RECRUITING Phase PHASE4
NCT06267144 Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer Status RECRUITING Phase N/A
NCT06262555 Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer Status RECRUITING Phase NA
NCT06262386 Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial Status RECRUITING Phase NA
NCT06255197 Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers Status RECRUITING Phase N/A
NCT06255041 Detection of Cancer in Breath Samples by Trained Detection Dogs Status COMPLETED Phase N/A
NCT06252233 Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer Status RECRUITING Phase NA
NCT06252129 Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens Status RECRUITING Phase NA
NCT06251570 Evaluation of Dual Task Performance and Respiratory Muscle Endurance in Patients With Lung Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06245343 Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer Status RECRUITING Phase NA
NCT06244355 Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer Status RECRUITING Phase N/A
NCT06244264 The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis Status RECRUITING Phase NA
NCT06236516 One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors Status COMPLETED Phase NA
NCT06234735 Physical Activity Behavioral Change Intervention in Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT06232083 A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) Status RECRUITING Phase PHASE1
NCT06229340 Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations Status RECRUITING Phase PHASE2
NCT06227897 Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA). Status WITHDRAWN Phase PHASE2